Drug intelligence / Profile preview

MucoClyns

Development stage: Unknown
Lead developer: Sonoma Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

**MucoClyns** is a ready-to-use, alcohol-free topical decontamination spray based on Sonoma Pharmaceuticals' patented Microcyn Technology. It is an electrolyzed-water solution containing sodium chloride, with sodium hypochlorite and hypochlorous acid as ancillary antimicrobial components. The product is intended for cleansing mucous membranes, cuts, abrasions, burns, and other body surfaces immediately after a potential infectious exposure and before professional medical care. Its antimicrobial activity is based on local oxidative disruption and physiological decontamination of microorganisms rather than binding to a specific human molecular target. ([sonomapharma-eu.com](https://sonomapharma-eu.com/mucoclyns/))

Brand names: MucoClyns

Beyond the preview

Go deeper on MucoClyns.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MucoClyns.

Explore the full profile